Last 12 months
Inside the activity.
0 purchase rows · 279 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 31 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 111 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 106 |
| Apr 2026 | 0 | 14 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2025 Filed May 19, 2025 20:17 UTC |
BONNEY MICHAEL WDirector
|
SaleCommon Stock | 301 | $275.63 | $82,964.63 |
DisclosureSEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 8 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,257 F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025. F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $275.11 to $276.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:17 UTC |
BONNEY MICHAEL WDirector
|
SaleCommon Stock | 882 | $273.75 | $241,447.50 |
DisclosureSEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 7 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,558 F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025. F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $273.61 to $274.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:17 UTC |
BONNEY MICHAEL WDirector
|
SaleCommon Stock | 660 | $273.16 | $180,285.60 |
DisclosureSEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 6 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,440 F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025. F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $272.60 to $273.59. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:17 UTC |
BONNEY MICHAEL WDirector
|
SaleCommon Stock | 431 | $271.68 | $117,094.08 |
DisclosureSEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 5 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,100 F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025. F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $271.44 to $272.10. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:17 UTC |
BONNEY MICHAEL WDirector
|
SaleCommon Stock | 245 | $269.79 | $66,098.55 |
DisclosureSEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 4 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,531 F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025. F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $269.53 to $269.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:17 UTC |
BONNEY MICHAEL WDirector
|
SaleCommon Stock | 729 | $268.56 | $195,780.24 |
DisclosureSEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 3 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,776 F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025. F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $268.28 to $269.16. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:17 UTC |
BONNEY MICHAEL WDirector
|
SaleCommon Stock | 549 | $267.14 | $146,659.86 |
DisclosureSEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 2 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,505 F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025. F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $266.87 to $267.72. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:17 UTC |
BONNEY MICHAEL WDirector
|
Exercise / conversionCommon Stock | 11,250 | $131.21 | $1,476,112.50 |
DisclosureSEC source: 0001735276-25-000072 · edgardoc.xml · nonDerivative · entry 1 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:05 UTC |
PYOTT DAVID E IDirector
|
GrantStock Option (right to buy) · Derivative | 1,558 | $0.00 Strike: $258.35 | $0.00 |
DisclosureSEC source: 0001735276-25-000063 · edgardoc.xml · derivative · entry 3 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 Underlying: Common Stock · 1,558 shares Expires 2035-05-08 F3 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:05 UTC |
PYOTT DAVID E IDirector
|
GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000063 · edgardoc.xml · nonDerivative · entry 1 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 911 F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:07 UTC |
Ausiello Dennis ADirector
|
GrantStock Option (right to buy) · Derivative | 1,558 | $0.00 Strike: $258.35 | $0.00 |
DisclosureSEC source: 0001735276-25-000068 · edgardoc.xml · derivative · entry 3 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 Underlying: Common Stock · 1,558 shares Expires 2035-05-08 F3 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:07 UTC |
Ausiello Dennis ADirector
|
GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000068 · edgardoc.xml · nonDerivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 911 F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:07 UTC |
BONNEY MICHAEL WDirector
|
GrantStock Option (right to buy) · Derivative | 1,558 | $0.00 Strike: $258.35 | $0.00 |
DisclosureSEC source: 0001735276-25-000067 · edgardoc.xml · derivative · entry 3 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 Underlying: Common Stock · 1,558 shares Expires 2035-05-08 F3 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:07 UTC |
BONNEY MICHAEL WDirector
|
GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000067 · edgardoc.xml · nonDerivative · entry 1 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,804 F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:06 UTC |
BRANDICOURT OLIVIERDirector
|
GrantStock Option (right to buy) · Derivative | 1,558 | $0.00 Strike: $258.35 | $0.00 |
DisclosureSEC source: 0001735276-25-000066 · edgardoc.xml · derivative · entry 2 BRANDICOURT OLIVIER · CIK 0001508518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 Underlying: Common Stock · 1,558 shares Expires 2035-05-08 F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:06 UTC |
BRANDICOURT OLIVIERDirector
|
GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000066 · edgardoc.xml · nonDerivative · entry 1 BRANDICOURT OLIVIER · CIK 0001508518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 775 F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:06 UTC |
HAMBURG MARGARET ADirector
|
GrantStock Option (right to buy) · Derivative | 1,558 | $0.00 Strike: $258.35 | $0.00 |
DisclosureSEC source: 0001735276-25-000065 · edgardoc.xml · derivative · entry 2 HAMBURG MARGARET A · CIK 0001266917 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 Underlying: Common Stock · 1,558 shares Expires 2035-05-08 F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:06 UTC |
HAMBURG MARGARET ADirector
|
GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000065 · edgardoc.xml · nonDerivative · entry 1 HAMBURG MARGARET A · CIK 0001266917 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 911 F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:05 UTC |
KELLOGG PETER NDirector
|
GrantStock Option (right to buy) · Derivative | 1,558 | $0.00 Strike: $258.35 | $0.00 |
DisclosureSEC source: 0001735276-25-000064 · edgardoc.xml · derivative · entry 2 KELLOGG PETER N · CIK 0001226287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 Underlying: Common Stock · 1,558 shares Expires 2035-05-08 F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:05 UTC |
KELLOGG PETER NDirector
|
GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000064 · edgardoc.xml · nonDerivative · entry 1 KELLOGG PETER N · CIK 0001226287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 775 F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:04 UTC |
SCHULMAN AMY WDirector
|
GrantStock Option (right to buy) · Derivative | 1,558 | $0.00 Strike: $258.35 | $0.00 |
DisclosureSEC source: 0001735276-25-000061 · edgardoc.xml · derivative · entry 2 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 Underlying: Common Stock · 1,558 shares Expires 2035-05-08 F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:04 UTC |
SCHULMAN AMY WDirector
|
GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000061 · edgardoc.xml · nonDerivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,961 F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:05 UTC |
Reitan Colleen FDirector
|
GrantStock Option (right to buy) · Derivative | 1,558 | $0.00 Strike: $258.35 | $0.00 |
DisclosureSEC source: 0001735276-25-000062 · edgardoc.xml · derivative · entry 5 Reitan Colleen F · CIK 0001740730 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 Underlying: Common Stock · 1,558 shares Expires 2035-05-08 F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:05 UTC |
Reitan Colleen FDirector
|
GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000062 · edgardoc.xml · nonDerivative · entry 4 Reitan Colleen F · CIK 0001740730 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 775 F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:04 UTC |
Sigal Charles ElliottDirector
|
GrantStock Option (right to buy) · Derivative | 1,558 | $0.00 Strike: $258.35 | $0.00 |
DisclosureSEC source: 0001735276-25-000060 · edgardoc.xml · derivative · entry 3 Sigal Charles Elliott · CIK 0001661908 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 Underlying: Common Stock · 1,558 shares Expires 2035-05-08 F3 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:04 UTC |
Sigal Charles ElliottDirector
|
GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000060 · edgardoc.xml · nonDerivative · entry 1 Sigal Charles Elliott · CIK 0001661908 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 775 F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:03 UTC |
Bertozzi Carolyn RDirector
|
GrantStock Option (right to buy) · Derivative | 1,558 | $0.00 Strike: $258.35 | $0.00 |
DisclosureSEC source: 0001735276-25-000059 · edgardoc.xml · derivative · entry 2 Bertozzi Carolyn R · CIK 0001698766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 Underlying: Common Stock · 1,558 shares Expires 2035-05-08 F2 · derivative.exercise_date: The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:03 UTC |
Bertozzi Carolyn RDirector
|
GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000059 · edgardoc.xml · nonDerivative · entry 1 Bertozzi Carolyn R · CIK 0001698766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 775 F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 21:05 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
GiftCommon Stock | 41,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000047 · edgardoc.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,324 F1 · kind: The reported transaction involves a transfer of securities by bona fide gift for estate planning purposes to the Yvonne Greenstreet 2024 Irrevocable Trust Dtd 10/29/2024, of which the reporting person is neither the trustee nor a beneficiary. Read SEC document |
| April 16, 2025 Filed May 12, 2025 20:05 UTC |
Reitan Colleen FDirector
|
SaleCommon Stock | 36 | $232.86 | $8,382.96 |
DisclosureSEC source: 0001735276-25-000062 · edgardoc.xml · nonDerivative · entry 3 Reitan Colleen F · CIK 0001740730 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 20:09 UTC |
PYOTT DAVID E IDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,440 | $0.00 Strike: $88.95 | $0.00 |
DisclosureSEC source: 0001735276-25-000040 · edgardoc.xml · derivative · entry 4 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,440 shares Expires 2025-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on September 5, 2024. The options exercised and sold by the reporting person were due to expire on December 18, 2025. F3 · derivative.exercise_date: This stock option was fully vested and exercisable as of December 18, 2016. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 20:09 UTC |
PYOTT DAVID E IDirector
|
SaleCommon Stock | 7,440 | $299.00 | $2,224,560.00 |
DisclosureSEC source: 0001735276-25-000040 · edgardoc.xml · nonDerivative · entry 2 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136 F1 · kind: The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on September 5, 2024. The options exercised and sold by the reporting person were due to expire on December 18, 2025. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 20:09 UTC |
PYOTT DAVID E IDirector
|
Exercise / conversionCommon Stock | 7,440 | $88.95 | $661,788.00 |
DisclosureSEC source: 0001735276-25-000040 · edgardoc.xml · nonDerivative · entry 1 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on September 5, 2024. The options exercised and sold by the reporting person were due to expire on December 18, 2025. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 20:10 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,445 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001735276-25-000041 · edgardoc.xml · derivative · entry 6 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,445 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024. F4 · derivative.exercise_date: This stock option was fully vested and exercisable as of December 20, 2020. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 20:10 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 5,445 | $300.00 | $1,633,500.00 |
DisclosureSEC source: 0001735276-25-000041 · edgardoc.xml · nonDerivative · entry 3 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,221 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 20:10 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
Exercise / conversionCommon Stock | 5,445 | $42.22 | $229,887.90 |
DisclosureSEC source: 0001735276-25-000041 · edgardoc.xml · nonDerivative · entry 2 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:10 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 4,321 | $285.00 | $1,231,485.00 |
DisclosureSEC source: 0001735276-25-000041 · edgardoc.xml · nonDerivative · entry 1 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,221 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 20:16 UTC |
SCHULMAN AMY WDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,750 | $0.00 Strike: $131.21 | $0.00 |
DisclosureSEC source: 0001735276-25-000037 · edgardoc.xml · derivative · entry 2 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,750 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The options exercised and held by the reporting person were due to expire on June 1, 2025. F2 · derivative.exercise_date: The stock option was fully vested as of June 1, 2016. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 20:16 UTC |
SCHULMAN AMY WDirector
|
Exercise / conversionCommon Stock | 2,750 | $131.21 | $360,827.50 |
DisclosureSEC source: 0001735276-25-000037 · edgardoc.xml · nonDerivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The options exercised and held by the reporting person were due to expire on June 1, 2025. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:22 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 71 | $242.93 | $17,248.03 |
DisclosureSEC source: 0001735276-25-000034 · edgardoc.xml · nonDerivative · entry 15 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,501 F9 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:22 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 324 | $241.68 | $78,304.32 |
DisclosureSEC source: 0001735276-25-000034 · edgardoc.xml · nonDerivative · entry 14 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,572 F9 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024. F15 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.40 to $241.85. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:22 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 328 | $240.95 | $79,031.60 |
DisclosureSEC source: 0001735276-25-000034 · edgardoc.xml · nonDerivative · entry 13 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,896 F9 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024. F14 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $240.18 to $241.17. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:22 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
SaleCommon Stock | 121 | $239.24 | $28,948.04 |
DisclosureSEC source: 0001735276-25-000034 · edgardoc.xml · nonDerivative · entry 12 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,224 F9 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024. F13 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $238.93 to $239.40. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:21 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 120 | $242.70 | $29,124.00 |
DisclosureSEC source: 0001735276-25-000032 · edgardoc.xml · nonDerivative · entry 15 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,542 F10 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024. F17 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.46 to $242.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:21 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 198 | $241.60 | $47,836.80 |
DisclosureSEC source: 0001735276-25-000032 · edgardoc.xml · nonDerivative · entry 14 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,662 F10 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024. F16 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.21 to $242.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:21 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 343 | $240.92 | $82,635.56 |
DisclosureSEC source: 0001735276-25-000032 · edgardoc.xml · nonDerivative · entry 13 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,860 F10 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024. F15 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $240.18 to $241.17. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:21 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 147 | $239.25 | $35,169.75 |
DisclosureSEC source: 0001735276-25-000032 · edgardoc.xml · nonDerivative · entry 12 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,203 F10 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024. F14 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $238.93 to $239.40. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:23 UTC |
Hesslein Robert W.EVP, CLO and Secretary
|
GrantStock Option (right to buy) · Derivative | 1,529 | $0.00 Strike: $243.53 | $0.00 |
DisclosureSEC source: 0001735276-25-000035 · edgardoc.xml · derivative · entry 2 Hesslein Robert W. · CIK 0001585018 · EVP, CLO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,529 Underlying: Common Stock · 1,529 shares Expires 2035-03-03 F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:23 UTC |
Hesslein Robert W.EVP, CLO and Secretary
|
GrantCommon Stock | 757 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-25-000035 · edgardoc.xml · nonDerivative · entry 1 Hesslein Robert W. · CIK 0001585018 · EVP, CLO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,002 F1 · shares: These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:22 UTC |
Fitzgerald Kevin JosephCSO & EVP, Head of Research
|
GrantStock Option (right to buy) · Derivative | 7,819 | $0.00 Strike: $243.53 | $0.00 |
DisclosureSEC source: 0001735276-25-000034 · edgardoc.xml · derivative · entry 17 Fitzgerald Kevin Joseph · CIK 0001886431 · CSO & EVP, Head of Research 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,819 Underlying: Common Stock · 7,819 shares Expires 2035-03-03 F17 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.